Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer

NCT07756593 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Metastatic Prostate Cancer

Interventions

BIOLOGICAL: Sipuleucel-T
BIOLOGICAL: N803

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]